CAN
DAWN

Cetera Advisor Networks’s Day One Biopharmaceuticals DAWN Stock Holding History

Cetera Advisor Networks’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$449K Buy
27,165
+2,219
+9% +$33.2K ﹤0.01% 2005
2023
Q4 		$364K Sell
24,946
-2,693
-10% -$32.6K ﹤0.01% 2100
2023
Q3 		$339K Buy
27,639
+16,139
+140% +$211K ﹤0.01% 2064
2023
Q2 		$137K Buy
11,500
+1,500
+15% +$19.6K ﹤0.01% 2420
2023
Q1 		$134K Buy
+10,000
New +$195K ﹤0.01% 2400

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cetera Advisor Networks's DAWN Position: Q1 2024 in Review

Cetera Advisor Networks increased its Day One Biopharmaceuticals (DAWN) stake by 8.9% in Q1 2024, buying an estimated $33.2K and bringing the position to 27,165 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #2005.

Cetera Advisor Networks first reported a position in DAWN in Q1 2023 and has held it in 5 quarters since. 149 funds tracked by Wall St. Rank hold DAWN as of Q1 2024.

  • Cetera Advisor Networks held 27,165 shares of Day One Biopharmaceuticals worth $449K as of Q1 2024.
  • Cetera Advisor Networks bought 2,219 Day One Biopharmaceuticals shares in Q1 2024, an estimated $33.2K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2005 holding.
  • Cetera Advisor Networks first reported a position in Day One Biopharmaceuticals in Q1 2023 and has held it in 5 quarters since.
  • 149 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.